New Drug ApprovalHUTCHMED Secures Third Approved Indication in China for ORPATHYS HUTCHMED Secures Third Approved Indication in China for ORPATHYS Read Post »
New Drug ApprovalFDA Approves CASGEVY for Children Aged 2 and Older With SCD and TDT FDA Approves CASGEVY for Children Aged 2 and Older With SCD and TDT Read Post »
Clinical TrialsGlenmark Advances Global Phase 3 Trial of Trastuzumab Rezetecan in Platinum... Glenmark Advances Global Phase 3 Trial of Trastuzumab Rezetecan in Platinum... Read Post »
Clinical TrialsVOYXACT Becomes First APRIL Inhibitor to Stabilize eGFR in Phase 3 VISIONAR... VOYXACT Becomes First APRIL Inhibitor to Stabilize eGFR in Phase 3 VISIONAR... Read Post »
Clinical TrialsCan-Fite Reports Durable Survival with Namodenoson in Heavily Pretreated Pa... Can-Fite Reports Durable Survival with Namodenoson in Heavily Pretreated Pa... Read Post »
Clinical TrialsNew ITC Analyses Support Overall Survival Benefit of Mogamulizumab in CTCL New ITC Analyses Support Overall Survival Benefit of Mogamulizumab in CTCL Read Post »
Clinical TrialsBeOne’s BRUKINSA Plus Rituximab Cuts Progression Risk by 43% in First-Lin... BeOne’s BRUKINSA Plus Rituximab Cuts Progression Risk by 43% in First-Lin... Read Post »
Clinical TrialsSkyhawk Reports Positive 12-Month Phase 1/2 SKY-0515 Data in HuntingtonR... Skyhawk Reports Positive 12-Month Phase 1/2 SKY-0515 Data in HuntingtonR... Read Post »
Clinical TrialsSanofi’s Nexviazyme Meets All Endpoints in Phase 3 Baby-COMET Study for I... Sanofi’s Nexviazyme Meets All Endpoints in Phase 3 Baby-COMET Study for I... Read Post »
Clinical TrialsAkebia Ends VOICE Trial Early as Vafseo Shows Superior Safety Over ESAs Akebia Ends VOICE Trial Early as Vafseo Shows Superior Safety Over ESAs Read Post »
Clinical TrialsVistagen Eyes New Registration Strategy After Fasedienol Phase 3 Miss Vistagen Eyes New Registration Strategy After Fasedienol Phase 3 Miss Read Post »
Clinical TrialsAscendis’s TransCon CNP Improved Leg Alignment Through Two Years in C... Ascendis’s TransCon CNP Improved Leg Alignment Through Two Years in C... Read Post »
Clinical TrialsAbivax Reports Positive Phase 3 Maintenance Data for Obefazimod in Refracto... Abivax Reports Positive Phase 3 Maintenance Data for Obefazimod in Refracto... Read Post »
New Drug ApprovalFDA Expands ZORYVE Cream Approval to Children as Young as 2 Years with Plaq... FDA Expands ZORYVE Cream Approval to Children as Young as 2 Years with Plaq... Read Post »
Clinical TrialsEVO756 Fails Phase 2b CSU Trial, Evommune Shifts Focus to Atopic Dermatitis... EVO756 Fails Phase 2b CSU Trial, Evommune Shifts Focus to Atopic Dermatitis... Read Post »
Clinical TrialsAbbVie Phase 3 Trial Shows Epcoritamab Combination Significantly Extends Pr... AbbVie Phase 3 Trial Shows Epcoritamab Combination Significantly Extends Pr... Read Post »
Clinical TrialsViatris Reports Positive Phase 3 Results for VR-205 in Japanese IgA Nephrop... Viatris Reports Positive Phase 3 Results for VR-205 in Japanese IgA Nephrop... Read Post »
Clinical TrialsGrünenthal Moves NOP Agonist into Phase II After Positive Phase I Results Grünenthal Moves NOP Agonist into Phase II After Positive Phase I Results Read Post »
Clinical TrialsAvecho Advances Phase III CBD Insomnia Trial After Positive Interim Review ... Avecho Advances Phase III CBD Insomnia Trial After Positive Interim Review ... Read Post »
Clinical TrialsSamsung Bioepis Reports Positive Clinical Results for Pembrolizumab Biosimi... Samsung Bioepis Reports Positive Clinical Results for Pembrolizumab Biosimi... Read Post »
New Drug ApprovalEU Approves Enhertu as First HER2 Tumor-Agnostic Therapy for Advanced Solid... EU Approves Enhertu as First HER2 Tumor-Agnostic Therapy for Advanced Solid... Read Post »
Clinical TrialsOral Infigratinib Phase 3 PROPEL 3 Results Published in NEJM, Adding New Ar... Oral Infigratinib Phase 3 PROPEL 3 Results Published in NEJM, Adding New Ar... Read Post »
Clinical TrialsAstra Zeneca’s Efzimfotase Alfa Improves Bone Health in Hypophosphata... Astra Zeneca’s Efzimfotase Alfa Improves Bone Health in Hypophosphata... Read Post »
Clinical TrialsEpicrispr’s EPI-321 Shows Early Muscle Gain and Favorable Safety in First... Epicrispr’s EPI-321 Shows Early Muscle Gain and Favorable Safety in First... Read Post »
Clinical TrialsHemab Reports Positive Early Data for HMB-002 in Von Willebrand Disease, Ad... Hemab Reports Positive Early Data for HMB-002 in Von Willebrand Disease, Ad... Read Post »
Clinical TrialsCumberland Reports New Biomarker Data Supporting Ifetroban’s Heart-Pr... Cumberland Reports New Biomarker Data Supporting Ifetroban’s Heart-Pr... Read Post »
New Drug ApprovalFDA Approves Veligrotug as First Treatment for Active and Chronic Thyroid E... FDA Approves Veligrotug as First Treatment for Active and Chronic Thyroid E... Read Post »
New Drug ApprovalFDA Approves SKYRIZI for Children with Plaque Psoriasis and Psoriatic Arthr... FDA Approves SKYRIZI for Children with Plaque Psoriasis and Psoriatic Arthr... Read Post »
Clinical TrialsJohnson & Johnson Reports New IMAAVY Data Supporting Early Disease Cont... Johnson & Johnson Reports New IMAAVY Data Supporting Early Disease Cont... Read Post »
Clinical TrialsCAR T-Cell Therapy Delivers 10-Year Remissions in B-Cell Lymphoma, Strength... CAR T-Cell Therapy Delivers 10-Year Remissions in B-Cell Lymphoma, Strength... Read Post »
Clinical TrialsCapricor Reports Five-Year Deramiocel Data Showing Sustained Muscle and Car... Capricor Reports Five-Year Deramiocel Data Showing Sustained Muscle and Car... Read Post »
Clinical TrialsServier to Present Three-Year OJEMDA Data and Caregiver Survey at ISPNO 202... Servier to Present Three-Year OJEMDA Data and Caregiver Survey at ISPNO 202... Read Post »
Clinical TrialsTegoprubart Shows Superior Kidney Function to Tacrolimus in Phase 2 BESTOW ... Tegoprubart Shows Superior Kidney Function to Tacrolimus in Phase 2 BESTOW ... Read Post »
Clinical TrialsAxsome Doses First Patient in Phase 3 FOCUS-3 Trial of Solriamfetol for Ado... Axsome Doses First Patient in Phase 3 FOCUS-3 Trial of Solriamfetol for Ado... Read Post »
Clinical TrialsGENFIT Reports Positive Results for GNS561 Combination in KRAS-Mutated Chol... GENFIT Reports Positive Results for GNS561 Combination in KRAS-Mutated Chol... Read Post »
New Drug ApprovalFDA Approves KEYTRUDA Plus Trodelvy for First-Line Advanced Triple-Negative... FDA Approves KEYTRUDA Plus Trodelvy for First-Line Advanced Triple-Negative... Read Post »
Clinical TrialsCentanafadine Improves ADHD and Anxiety Symptoms in Phase 3b Trial Ahead of... Centanafadine Improves ADHD and Anxiety Symptoms in Phase 3b Trial Ahead of... Read Post »
Clinical TrialsCeleCor Submits NDA for Zalunfiban After Positive CeleBrate Trial Results CeleCor Submits NDA for Zalunfiban After Positive CeleBrate Trial Results Read Post »
Clinical TrialsHUTCHMED Reports Positive Results for Fanregratinib in FGFR2-Altered Intrah... HUTCHMED Reports Positive Results for Fanregratinib in FGFR2-Altered Intrah... Read Post »
Clinical TrialsAvacta Reports Positive Data for Faridoxorubicin in Salivary Gland Cancer Avacta Reports Positive Data for Faridoxorubicin in Salivary Gland Cancer Read Post »
New Drug ApprovalTrodelvy Wins FDA Approval for First-Line mTNBC After EU Approval Trodelvy Wins FDA Approval for First-Line mTNBC After EU Approval Read Post »
New Drug ApprovalFDA Approves IBRANCE for HR+/HER2+ Metastatic Breast Cancer FDA Approves IBRANCE for HR+/HER2+ Metastatic Breast Cancer Read Post »
New Drug ApprovalFDA Approves TRYNGOLZA (Olezarsen) to Reduce Triglycerides and Acute Pancre... FDA Approves TRYNGOLZA (Olezarsen) to Reduce Triglycerides and Acute Pancre... Read Post »
Clinical TrialsCognition Aligns with FDA on Phase 3 Pathway for Zervimesine in Dementia wi... Cognition Aligns with FDA on Phase 3 Pathway for Zervimesine in Dementia wi... Read Post »
Clinical TrialsREGENXBIO Completes RGX-202 Confirmatory Study Enrollment, Advances Duchenn... REGENXBIO Completes RGX-202 Confirmatory Study Enrollment, Advances Duchenn... Read Post »
Clinical TrialsAbsci Reports Positive Phase 1 Interim Data for ABS-201, Advances Novel Hai... Absci Reports Positive Phase 1 Interim Data for ABS-201, Advances Novel Hai... Read Post »
New Drug ApprovalPADCEV Plus Keytruda Wins EU Approval for Cisplatin-Ineligible MIBC PADCEV Plus Keytruda Wins EU Approval for Cisplatin-Ineligible MIBC Read Post »
Clinical TrialsVerastem Reports Encouraging Phase 1/2 Results for KRAS G12D Inhibitor VS-7... Verastem Reports Encouraging Phase 1/2 Results for KRAS G12D Inhibitor VS-7... Read Post »
New Drug ApprovalSanofi’s Wayrilz Wins Japan Approval for Chronic Immune Thrombocytopenia Sanofi’s Wayrilz Wins Japan Approval for Chronic Immune Thrombocytopenia Read Post »
New Drug ApprovalEU Authorizes MAVIRET for Adults and Children with Acute Hepatitis C EU Authorizes MAVIRET for Adults and Children with Acute Hepatitis C Read Post »
